Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis. Issue 10 (7th March 2017)

• Record Type: Journal Article
• Authors: Lindner, Samuel M.; Fordyce, Christopher B.; Hellkamp, Anne S.; Lokhnygina, Yuliya; Piccini, Jonathan P.; Breithardt, Günter; Mahaffey, Kenneth W.; Singer, Daniel E.; Hacke, Werner; Halperin, Jonathan L.; Hankey, Graeme J.; Berkowitz, Scott D.; Nessel, Christopher C.; Becker, Richard C.; Fox, Keith A.A.; Patel, Manesh R.
• Is Part Of: Circulation. Volume 135:Issue 10(2017)
• Publication Date: 2017-03-07
• Subjects: atrial fibrillation -- renal function; Blood -- Circulation -- Periodicals; Cardiovascular system -- Periodicals; Cardiology -- Periodicals; Heart -- Diseases -- Periodicals; Blood Circulation; Cardiovascular System; Vascular Diseases; 616.1
• DOI: 10.1161/CIRCULATIONAHA.116.024666
• Languages: English
• ISSNs: 0009-7322